Skip to the story
17 Nov 2026 · 10:31 UTC
back to the wire science / research · asia-pacific 16,468 reads Save
17:45
17:45 UTC

uBiome Introduces at-Home Women’s Health Screening Kit

17:45

uBiome has launched a new at-home testing service aimed at women’s reproductive health. The product, called SmartJane, allows users to examine their vaginal health conveniently from their homes, addressing a range of concerns through genetic analysis.

uBiome Introduces at-Home Women’s Health Screening Kit
uBiome Introduces at-Home Women’s Health Screening Kit Photo: Krzysztof Popławski / Wikimedia Commons, CC BY-SA 4.0

Details of the SmartJane Test

SmartJane screens for 23 types of vaginal flora, 19 strains of human papillomavirus (HPV), and several sexually transmitted infections (STIs), including Chlamydia and gonorrhea. The test can also genotype HPV strains to provide detailed insights into specific risks.

Consumers can access the test by ordering online or through their healthcare providers. The process involves collecting a sample at home, which is then sent to a regulated laboratory for analysis. The laboratories carrying out the testing are CLIA-certified and CAP-accredited, ensuring compliance with quality standards. Results are securely delivered via a HIPAA-compliant platform.

Unique Features and Scientific Backing

What distinguishes SmartJane from similar products is its advanced genetic testing capability. This allows for in-depth identification of pathogens, including asymptomatic infections like Mycoplasma genitalium, which is linked to infertility and often goes unnoticed.

uBiome reports having collected thousands of samples over five years, with a near-perfect accuracy rate. The company plans to publish scientific research validating its methods, further cementing the test's credibility.

Role in Women’s Healthcare

The test is designed not as a replacement for traditional clinical testing but as a supplementary tool, especially valuable for women who do not regularly undergo screenings like Pap smears. It aims to reduce barriers to testing by offering a private, accessible alternative.

Research shows women are more than twice as likely to self-test than to immediately visit a healthcare provider, indicating a significant trend toward self-monitoring health. SmartJane fits within this movement, empowering women to take proactive steps regarding their reproductive health.

Future Outlook

uBiome emphasizes that its goal is to make innovative testing options more accessible. The company positions SmartJane as part of a broader effort to improve women's health management through easy-to-use, scientifically validated tools.

As self-testing becomes more prevalent, SmartJane represents an important development in the landscape of preventive health, providing women with enhanced insights and greater autonomy over their reproductive wellness.

Corrections and clarifications: contact@avorz.com
How this was reported: /how-we-report/